CP-601927

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameCP-601927
Drug Alias NameCP-601927
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscle-type nicotinic acetylcholine receptor agonists
TargetsMuscle-type nicotinic acetylcholine receptor
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksN/A